Akorn Recalls Sodium Chloride Ophthalmic Ointment Due to Particulate Matter
Akorn, Inc. is recalling specific lots of Sodium Chloride Ophthalmic Ointment USP, 5%, due to the presence of brown particulate matter inside the tubes.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which indicates the product is unlikely to cause adverse health consequences. The hazard is limited to particulate matter from the tube material.
Plain-English summary
Akorn, Inc. is recalling 720 tubes of Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes (NDC 17478-622-35). The recall is due to the presence of brown spots observed on the inside of the product tubes. These spots were identified as tin with trace copper, which are the base materials of construction for the tube.
The affected lots are 8B66A (Exp. 01/2021), 8C91A (Exp. 02/2021), 8F07A and 8F16A (Exp. 05/2021), and 8F13A (Exp. 07/2021). The product was distributed nationwide within the United States and Puerto Rico.
Consumers should check their inventory for these specific lot numbers and expiration dates. If the product is found, it should be returned to the source of purchase or the manufacturer.
The recalled product
- Product
- Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-622-35
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 720
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot #: 8B66A
- Exp. Date 01/2021
- Lot 8C91A
- Exp. Date 02/2021
- Lots 8F07A
- 8F16A
- Exp. Date 05/2021
- Lot 8F13A
- Exp. Date 07/2021.
Distribution
Part of a larger recall action
This product is one of 3 recalled by Akorn, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26